CALA logo

Calithera Biosciences (CALA)

Profile

Full Name

Calithera Biosciences, Inc.

Ticker Symbol

CALA

Exchange

NASDAQ

Country

United States

IPO

October 2, 2014

Indexes

Not included

Employees

8

Key Details

Price

$0.00(0.00%)

Market cap

$4872.50(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$7.94(+74.52% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Nov 15, 22 SVB Leerink
Market Perform
Nov 15, 22 Ladenburg Thalmann
Neutral
Aug 29, 22 HC Wainwright & Co.
Buy
Aug 16, 22 SVB Leerink
Outperform
May 11, 22 Wells Fargo
Equal-Weight
Apr 4, 22 SVB Leerink
Outperform
Jan 31, 22 Ladenburg Thalmann
Buy
Jan 20, 22 SVB Leerink
Outperform
Nov 8, 21 HC Wainwright & Co.
Neutral
Nov 5, 21 William Blair
Market Perform

Institutional Ownership

  • What is the ticker symbol for Calithera Biosciences?
  • Does Calithera Biosciences pay dividends?
  • What sector is Calithera Biosciences in?
  • What industry is Calithera Biosciences in?
  • What country is Calithera Biosciences based in?
  • When did Calithera Biosciences go public?
  • Is Calithera Biosciences in the S&P 500?
  • Is Calithera Biosciences in the NASDAQ 100?
  • Is Calithera Biosciences in the Dow Jones?
  • When was Calithera Biosciences's last earnings report?
  • When does Calithera Biosciences report earnings?
  • Should I buy Calithera Biosciences stock now?

What is the ticker symbol for Calithera Biosciences?

The ticker symbol for Calithera Biosciences is NASDAQ:CALA

Does Calithera Biosciences pay dividends?

No, Calithera Biosciences does not pay dividends

What sector is Calithera Biosciences in?

Calithera Biosciences is in the Healthcare sector

What industry is Calithera Biosciences in?

Calithera Biosciences is in the Biotechnology industry

What country is Calithera Biosciences based in?

Calithera Biosciences is headquartered in United States

When did Calithera Biosciences go public?

Calithera Biosciences's initial public offering (IPO) was on October 2, 2014

Is Calithera Biosciences in the S&P 500?

No, Calithera Biosciences is not included in the S&P 500 index

Is Calithera Biosciences in the NASDAQ 100?

No, Calithera Biosciences is not included in the NASDAQ 100 index

Is Calithera Biosciences in the Dow Jones?

No, Calithera Biosciences is not included in the Dow Jones index

When was Calithera Biosciences's last earnings report?

Calithera Biosciences's most recent earnings report was on Apr 14, 2025

When does Calithera Biosciences report earnings?

The date for Calithera Biosciences's next earnings report has not been announced yet

Should I buy Calithera Biosciences stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page